Location History:
- Grand Cayman, KY (2017)
- Taipei, TW (2019 - 2023)
Company Filing History:
3 out of 5 
2 out of 6 
1 out of 832,843 Years Active: 2017-2023
Title: Chi-Chiang Tu: Innovator in Pharmaceutical Compositions
Introduction
Chi-Chiang Tu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of melanoma and fat reduction. With a total of 5 patents, his work has the potential to impact many lives.
Latest Patents
Chi-Chiang Tu's latest patents include a method for treating melanoma. This patent provides a pharmaceutical composition for treating melanoma, which includes a benzenesulfonamide derivative and a pharmaceutically acceptable carrier. The method involves administering this composition to a subject in need, and it also outlines the use of the pharmaceutical composition in the manufacture of a medicament for treating melanoma. Another notable patent focuses on reducing fat by administering benzenesulfonamide compositions. This composition is designed to reduce fat in the body and includes a benzenesulfonamide derivative along with a pharmaceutically or cosmetically acceptable carrier. The method described allows for fat ablation or lipolysis by administering the composition to the subject, and it also addresses the prevention or treatment of diseases related to fat accumulation.
Career Highlights
Throughout his career, Chi-Chiang Tu has worked with notable companies such as Gongwin Biopharm Holdings Co., Ltd. and Gongwin Biopharm Co., Ltd. His experience in these organizations has contributed to his innovative research and development in the pharmaceutical sector.
Collaborations
Chi-Chiang Tu has collaborated with several professionals in his field, including Chuan-Ching Yang and Mao-Yuan Lin. These collaborations have likely enhanced his research and led to the successful development of his patents.
Conclusion
Chi-Chiang Tu is a distinguished inventor whose work in pharmaceutical compositions has the potential to revolutionize treatments for melanoma and fat reduction. His contributions to the field are noteworthy and demonstrate his commitment to innovation in healthcare.